Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Mar 11, 2013
The 2nd Circuit Court of Appeal's recent conclusion in Caronia, that off-label marketing is 'protected free speech,' could have a dramatic impact on promotion of prescription drugs, health care, government prosecution of drug companies (yielding billions in settlements), doctors and lawyers. On The American Law Journal, host Christopher Naughton moderates a panel discussion with New York criminal law attorney Jennifer L. McCann who represented pharma rep Alfred Caronia; plaintiff's counsel Brian J. McCormick, Jr. of Sheller, P.C.; award-winning journalist Ed Silverman with Pharmalot; and from CNN Washington, D.C. studios, former FDA counsel Anne K. Walsh, now representing drug companies with Hyman, Phelps & McNamara. For more information, visit LawJournalTV.com.